JET 2021 Program Detail

JET 2021 Program Detail Session No A1

Friday, February 12, 2021 9:00-10:30 Hall A

Theme Main Live Demonstration #1

Sub-theme Fight for calcified FP lesion

Co-sponsors: W. L. Gore & Associates G.K. / NIPRO CORPORATION Century Medical, Inc. / KANEKA MEDICAL PRODUCTS. / Cardinal Health Japan

Language English

MODERATOR Masato Nakamura

MODERATOR Masahiko Fujihara

FACILITATOR Makoto Utsunomiya

PANEL Hiroshi Ando

PANEL Keisuke Hirano

PANEL Shinsuke Mori

PANEL Ramon Varcoe

PANEL Po-Jen Ko

PANEL Sorracha Rookkapan

Operator Osamu Iida

Kansai Rosai Hospital CASE 01 Severe calcified lesion

Operator Tatsuya Nakama

Tokyo Bay Urayasu

Ichikawa Medical Center

CASE 02 Severe calcified lesion

Theme;大腿膝窩動脈病変の最大の敵である石灰化、慢性期開存率を維持するにはいかに大きな

ゲインをとるかが鍵。トップオペレーターのアグレッシブな Preparation は必見。破ってバイアバン？

SUPERA って留置が難しいよね？このライブを見れば目から鱗。SUPERA ステントの留置の極意全て

お見せします！

Aggressive Prep. and device selection for FP severely calcified lesions

Short

Lecture

Speech

(min) Title and Speaker

1. 6

What does Viabahn stent-graft change in our clinical

practice? Learn from the clinical and physician-initiated

study?

Terutoshi Yamaoka

2. 6 How to implant Viabahn stent-graft optimally?

Jen Kuang Lee

3. 6

What does SUPERA stent change in our clinical practice for

calcified FP lesion?

Masahiko Fujihara

4. 6 How to implant Supera stent optimally?

Daizo Kawasaki

JET 2021 Program Detail

Session No A2



Sub-theme Low dose DCB vs High dose DCB for common FP lesion

Co-sponsors: Boston Scientific Japan K.K.

Medtronic Japan Co., Ltd.

Language English

MODERATOR Yoshimitsu Soga

MODERATOR Naoto Inoue

FACILITATOR Michinao Tan

PANEL Taketsugu Tsuchiya

PANEL Shunsuke Ozaki

PANEL Akira Miyamoto

PANEL Edward Tieng Chek Choke

PANEL Young guk Ko

PANEL Hsuan Li Huang

Operator Osamu Iida

Kansai Rosai Hospital CASE 03 Low & High dose DCB


Tokyo Bay Urayasu


CASE 04 Low & High dose DCB

Theme; COMPARE study で low & high dose DCB の結果が明らかに、実臨床でもその効果は同等

なのか？あるいは病変評価、IVUS 評価、Prep.の工夫などでもっと成績が良くなるのか。

DCB choice in the real world from COMPARE study

Short

Lecture

Speech


1. 6

The preliminary result of POPCORN (PrOsPective

multiCenter registry Of dRug-coated ballooN for

femoropopliteal disease) registry

Yoshimitsu Soga

2. 6 Five-year outcomes of IN. PACT Global Asian subset

Young guk Ko

3. 6

What does Ranger emergence impact on our

practice?(Learn from First data from head-to-head

comparison of Ranger and IN.PACT drug-coated balloons)

Andrej Schmidt

4. 6

How to maximize the performance of DCB therapy in real-

world patients?

kazunori Horie


Session No A3



Sub-theme ISR/ISO

Co-sponsors: Philips Japan, Ltd.

Medicon, Inc. / Cardinal Health Japan

Language English

MODERATOR Daizo Kawasaki

MODERATOR Masahiko Fujihara

FACILITATOR Kenji Suzuki

PANEL Hideaki Aihara

PANEL Hideaki Obara

PANEL Ryoichi Kyuragi

PANEL Jackie Ho

PANEL Veera Suwanruangsri

PANEL Shannon Thomas


Tokyo Bay Urayasu


CASE 05 Joint lesion

Operator Osamu Iida

Kansai Rosai Hospital CASE 06 ISR/ISO

Theme; 意外と決まったやり方がない ISR/ISO に対する血管内治療。なんとかマリグナントサイクル

を断ち切るには如何すればいいの？CFA や POP は今までノンステンティングゾーンって言われてき

たけどなかなかいい Result が得られない状況。今あるデバイスでこの再狭窄病変、関節部病変に

トップオペレーターが臨みます。

What is best strategy for ISR & JOINT lesion

Short

Lecture

Speech


1. 6

Is Laser atherectomy still alive for the treatment of in-stent

restenosis (ISR)?

Ehrin Armstrong

2. 6

My experience of Laser atherectomy for the

femoropopliteal ISR treatment

Shin Okamoto

3. 6

The preliminary result of CAULIFLOWER Registry (Common

femoral Artery revascularization; investigation of the best

strategy from the multicenter retrospective real-world

registry)

Yo Iwata

4. 6 Are you kidding? Not do anything is better than endo in CFA.

Masayuki Hara


Session No A4



Sub-theme Above & Below the ankle EVT

Co-sponsors: Medtronic Japan Co., Ltd. / Medicon, Inc. / KANEKA MEDICAL PRODUCTS.

Boston Scientific Japan K.K. / ASAHI INTECC J-sales, INC. /Orbusneich Medical K. K.

Language English

MODERATOR Kazushi Urasawa

MODERATOR Hiroyoshi Yokoi

FACILITATOR Makoto Utsunomiya

PANEL Masashi Fukunaga

PANEL Kenjiro Kaneko

PANEL Masayoshi Kimura

PANEL Su Hong Kim

PANEL Yin Chun Skyi Pang

PANEL Wuttichai Saengprakai

Operator Osamu Iida

Kansai Rosai Hospital CASE 07 Above the ankle


Tokyo Bay Urayasu


CASE 08 Below the ankle

Theme; CLI 症例における適切な血行再建とは? 飯田先生からは Above the ankle lesion に IVUS で

評価すると以外ともっと大きい径のバルーンで拡げる事が創部への血流確保に必要であるというメッ

セージ。仲間先生からは創傷治癒を得るには時にはアグレッシブな Below the ankle インターベンシ

ョンが必要であるというメッセージを症例を通じて披露してもらいます。

Aggressive Above & Below the ankle EVT for CLI

Short

Lecture

Speech


1. 6 6 minutes summarizing about Global vascular guideline

Makoto Utsunomiya

2. 6

Doe DCB adversely impact on CLI outcomes? Learn from

RADISH (Roles of Angioplasty with Drug-coated balloon for

chronic ISchemia in wound Healing) study

Yosuke Hata

3. 6 Optimizing SFA in CLTI with DES. Results from RCTs and Real-

world registries. DES rather than DCB, SG, and IWS should

be the first-line therapy for much more complex lesion

Steven Kum

4. 6

The determinant factors for successful of BTK CTO wire

crossing

Michinao Tan


Session No A5



Sub-theme This is a real complex (no-sponsor live)

Language English

MODERATOR Takao Ohki

MODERATOR Daizo Kawasaki

FACILITATOR Masahiko Fujihara

PANEL Terutoshi Yamaoka

PANEL Hiroshi Banno

PANEL Yasutaka Yamauchi

PANEL Donghoon Choi

PANEL Chia-Hsun Lin

PANEL Ramon Varcoe

Operator Osamu Iida

Kansai Rosai Hospital CASE 09 Calcification


Tokyo Bay Urayasu


CASE 10 Calcification

Theme; 本日の最終決戦、実は皆さんこういう症例で悩まれていませんか？日常臨床で遭遇する

複雑病変！トップオペレーターの一番信頼しているデバイスで治療します。

Today’s final round. This is non-sponsored LIVE.

Fight complex lesion with operator’s favorite devices!!

Short

Lecture

Speech


1. 6

Supera stenting for common femoral artery lesions: the

outcomes of Supera stent from my experience

Veera Suwanruangsri

2. 6

Endovascular Therapy for Leriche Syndrome: Tools,

Techniques and Strategies.

Po-Jen Ko

3. 6

Innovative Solutions to Complex Re-Do Open and

Endovascular CLI Patients

Shannon Thomas

4. 6 Long Term Results from the ABSORB BTK Trial

Ramon Varcoe

JET 2021 Program Detail Session No A6

Saturday, February 13, 2021 9:00-10:30 Hall A


Sub-theme Ao-Iliac intervention

Co-sponsors: W. L. Gore & Associates G.K. / Cardinal Health Japan

TERUMO CORPORATION

Language English

MODERATOR Osamu Iida

MODERATOR Makoto Utsunomiya

FACILITATOR Michinao Tan

PANEL Yusuke Miyashita

PANEL Junichi Tazaki

PANEL Takuya Haraguchi

PANEL Donghoon Choi

PANEL Po-Jen Ko

PANEL Veera Suwanruangsri

Operator Masahiko Fujihara

Kishiwada Tokushukai CASE 11 Aorto Iliac

Operator Daizo Kawasaki

Morinomiya Hospital CASE 12 Trans radial Iliac

Theme; 大動脈腸骨動脈病変は大事な足の血流の入口。VBX の適応症例、サイジングがいまいち

分からない貴方に必見。最近 Radial からのデバイス開発が進んでいるらしい、Radial でどこまでで

きるのかお見せします！

How to use VBX / new access site “Trans-radial” for Ao-Iliac disease

Short

Lecture

Speech


1. 6

Trans radial intervention is it an attractive alternative to the

conventional approach?

Norihiko Shinozaki

2. 6

What is the last piece of aortoiliac intervention? Learn from

AVOCADO I and II registry

Yusuke Tomoi

3. 6

Lessons I have learned from CHAOS registry (CHronic

Abdominal Aortic Occlusion, Asian Multicenter registry)

Naoki Fujimura

4. 6 How to avoid and manage life-threatening complications

during Aorto-iliac intervention?

Terutoshi Yamaoka


Session No A7



Sub-theme Fight for calcified FP lesion

Co-sponsors: Boston Scientific Japan K.K. / Philips Japan, Ltd.

Century Medical, Inc. / Medicon, Inc. / NIPRO CORPORATION

Language English


MODERATOR Shigeo Ichihashi

FACILITATOR Tatsuya Nakama

PANEL Nobuhito Kaneko

PANEL Kazuki Tobita

PANEL Shinya Sasaki

PANEL Hsuan Li Huang

PANEL Shannon Thomas

PANEL Sorracha Rookkapan


Kishiwada Tokushukai CASE 13 Calcified FP lesion


Morinomiya Hospital CASE 14 Calcified FP lesion

Theme; SFA 治療の最大の敵である石灰化、慢性期開存率を維持するには SUPERA か DES か！

DES って石灰化にも良いって聞くけど本当？近位部の石灰化病変って SUPERA おけるの？皆さんの

経験で議論しましょう！

Possibilities of Eluvia and SUPERA stent in calcified lesions

Short

Lecture

Speech


1. 6

The preliminary result of CAPSICUM (Contemporary

outcomes After Paclitaxel-eluting peripheral Stent

implantation for symptomatic lower limb IsChemia with

sUperficial feMoral or proximal popliteal lesion) registry

Osamu Iida

2. 6

Lessons I have learned from DESAFINADO registry (Full

metal DES is the best strategy in complex FP lesions)

Steven Kum

3. 6 SUPERA data from EUROPE (Recorded)

Chung-Ho Hsu

4. 6

Lessons I have learned from VMI-CFA (Clinical Trial

Investigating the Efficacy of the Supera Peripheral Stent

System for the Treatment of the Common Femoral Artery)

registry

Koen Deloose


Session No A8



Sub-theme DES or DCB

Co-sponsor: Boston Scientific Japan K.K.

Language English


MODERATOR Yoshimitsu Soga

FACILITATOR Terutoshi Yamaoka

PANEL Yoshinori Tsubakimoto

PANEL Makoto Sugihara

PANEL Hideyuki Takimura

PANEL Steven Kum

PANEL Chung-Dann Kan

PANEL Chung-Ho Hsu


Kishiwada Tokushukai CASE 15 Complex FP lesion


Morinomiya Hospital CASE 16 Simple lesion

Theme; Simple lesion には DCB、Complex lesion(3C1L;CTO,Calcification,CLI,Long lesion)には DES

でいいんですよね？

DCB or DES use depending on the lesion type

Short

Lecture

Speech


1. 8

My perspective of best DCB through the experience of more

than 10 DCBs use

Yoshimitsu Soga

2. 8

What does Ranger emergence impact on our practice?

Result from COMPARE study

Andrej Schmidt

3. 8 Pathological finding for DCB and DES use

Sho Torii


Session No A9



Sub-theme Management CLI

Co-sponsors: Medtronic Japan Co., Ltd. / KANEKA MEDICAL PRODUCTS. /

Medicon, Inc. / Orbusneich Medical K. K. / ASAHI INTECC J-sales, INC.

Language English

MODERATOR Kazushi Urasawa

MODERATOR Tatsuya Nakama

FACILITATOR Naoki Fujimura

PANEL Yoshito Yamamoto

PANEL Takashi Miura

PANEL Taku Kato

PANEL Jackie Ho

PANEL Su Hong Kim

PANEL Chia-Hsun Lin


Kishiwada Tokushukai CASE 17 BTK EVT

Operator Daizo Kawasaki, Masashi Fukunaga

Morinomiya Hospital CASE 18 EVT & Amputation at Cath labo

Theme; CLI 患者に対するスタンダードな EVT を岸和田よりお見せします。

森之宮からは EVT したけどその後創傷管理の仕方が今ひとつわからないと思っているあなたに

カテ室で循環器ができる最低限の創部処置についてお見せします。

Amputation after EVT at Cath labo

Short

Lecture

Speech


1. 6 What does IVUS illustrate in BTK intervention?

Tatsuya Nakama

2. 6 6 minutes summarizing about the latest guidelines

Nobuhiro Suematsu

3. 6

When and how to decide percutaneous Deep Venous

Arterialization (DVA)? More practical than you expect!

Steven Kum

4. 6 My super techniques for BTK and BTA reconstruction

Naoki Hayakawa


Session No A10



Sub-theme This is a real complex (no-sponsor live)

Language English



FACILITATOR Kenji Suzuki

PANEL Kazuki Tobita

PANEL Akio Kodama

PANEL Eiji Karashima

PANEL Yin Chun Skyi Pang

PANEL Chung-Dann Kan

PANEL Ramon Varcoe


Kishiwada Tokushukai CASE 19 Complex lesion


Morinomiya Hospital CASE 20 Complex lesion

Theme; 本日の最終決戦、実は皆さんこういう症例で悩まれていませんか？日常臨床で遭遇する

複雑病変！トップオペレーターの一番信頼しているデバイスで治療します。

Today’s final round. This is non-sponsored LIVE. Fight complex lesion with

operator’s favorite devices!!

Short

Lecture

Speech


1. 6

DCB vs DES for femoropopliteal artery disease: Korean

centers experience

Young guk Ko

2. 6

The novel technique with SUPERA stent for SFA proximal

lesion:PRESTO

Yin Chun Skyi Pang

3. 6

Sirolimus coated balloon: XTOSI trial results and updates on

the FUTURE SFA and FUTURE BTK randomized controlled

trials

Edward Tieng Chek Choke

4. 6 How to Choose Your Atherectomy Weapons Wisely During

Peripheral Intervention

Chung-Ho Hsu


Session No A11

Sunday, February 14, 2021, 9:00-10:30 Hall A

THEME 僕たちはどういきるか My life as endovascular specialist #1

Sub-THEME 若手医師への提言

Language Japanese

MODERATOR Shinsuke Nanto

MODERATOR Hiroyoshi Yokoi

PANEL All Speakers

Time Speech

(min)

QA


09:00- 3 Introduction

Shinsuke Nanto

09:03- 6 4 カテーテル治療医に将来性はあるのか？

Hiroyoshi Yokoi

09:13- 6 4 High Volume Center の地の利を生かし EVTを行う

Daizo Kawasaki

09:23- 6 4 大学病院で地の利を生かし EVTを行う

Junichi Tazaki

09:33- 6 4 自分の信念を貫くための転職（訪問診療）へ

Makoto Utsunomiya

09:43- 6 4 血管外科医の advantage を生かし EVT を行う

Terutoshi Yamaoka

09:53- 6 4 放射線科医の advantage を生かし EVT を行う

Masanori Inoue

10:03- 6 4 形成外科として CLI に向き合う

Norihiko Ohura

10:13- Conclusion and Summary

Hiroyoshi Yokoi


Session No A12

Sunday, February 14, 2021, 10:30-12:00 Hall A

THEME 僕たちはどういきるか My life as endovascular specialist #2

Sub-THEME 若手医師への提言

Language Japanese


MODERATOR Takao Ohki

PANEL All Speakers

Time Speech

(min)

QA


10:30- 3 Introduction

Takao Ohki

10:33- 6 4 データをまとめ、論文を書き続ける

Yoshimitsu Soga

10:43- 6 4 日本発のガイドラインを作る

Nobuyoshi Azuma

10:53- 6 4 海外でドでかい発表、そしてその後

Takashi Miura

11:03- 6 4 統計に携わる立場から PAD/EVTを俯瞰的に見る

Mitsuyoshi Takahara

11:13- 6 4 行政の立場から PAD/EVTを俯瞰的に見る

Shin Iwamoto

11:23- 6 4 学会・ライブ企画から PADを俯瞰的に見る

Masahiko Fujihara

11:33- 6 4 トップオピニオンリーダーとして生き続ける

Osamu Iida

11:43- 6 4 大木隆生からの宿題若いうちにすべきこと

Takao Ohki

11:53- 3 Conclusion and Summary

Osamu Iida

Date post:	20-Nov-2021
Category:	Documents
Upload:	others
View:	2 times
Download:	0 times

JET 2021 Program Detail

Documents